site-industries-cosmetiques A cover of Industries Cosmétiques magazine
Discover all the innovations in perfumery and cosmetics.
Discover our special report: Save the People. Enjoy your direct access!
If you prefer the paper edition, please subscribe to our magazine
- advertising -

[podcast] Ozalys, cosmetics for cancer survivors!

In this episode, Isabelle Guyomarch, President and CEO of CCI Production, answers Yaël Landau's questions about the Ozalys brand.
Ozalys is a range of 100 % cosmetics made in France, dedicated to women who are living or have lived with cancer.

Ozalys is a French laboratory that exports to 32 countries worldwide, and whose products are the result of three years of research and innovation to meet the specific needs of women in their fight against disease (olfactory and sensitive ultra-sensitivity, dry skin, painful scars, etc.). This brand maintains the high quality standards of luxury products, and selects raw materials adapted to the particular situation of these women, notably by banning any ingredient that might behave like hormones...

[siteorigin_widget class="WP_Widget_Custom_HTML"][/siteorigin_widget]

External resources

Sponsored content

site-industries-cosmetiques A vibrant advertisement for Croda Beauty featuring a close-up of orange flowers with a blurred background effect and the text "Croda Beauty, intelligent science to improve life" now includes Phytess.

Phytessence™ Osmanthus, the first geo-skincare botanical extract by Croda Beauty

Discover how this innovative natural ingredient helps the skin to better face climate change, particularly the harmful effects of sun rays and heat.
site-industries-cosmetiques A concentrated individual in a lab coat examining a small jar containing a pink substance, a pioneering cosmetic innovation using natural ingredients in Brittany.

Cosmetics innovation comes naturally in Bretagne

In north-west France, Bretagne has always been a seawardlooking region with its 2,730km coastline - the longest in the country.

Related articles

Our last issue

Listen to us!

Newsletter